The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Targeting the dynamic HSP90 complex in cancer
Open accessAbstract
The molecular chaperone heat shock protein 90 (HSP90) has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90. However, although recent reports of the early clinical efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete Small RNA-Generating Loci as Master Regulators of Transposon Activity in Drosophila
Brennecke, J., Aravin, A. A., Stark, A., Dus, M., Kellis, M., Sachidanandam, R., & Hannon, G. J. (2007) · Cell · doi:10.1016/j.cell.2007.01.043 · Cited by 2,524
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,387
Zou, J., Guo, Y., Guettouche, T., Smith, D. F., & Voellmy, R. (1998) · Cell · doi:10.1016/s0092-8674(00)81588-3 · Cited by 1,232
HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor
Kovacs, J. J., Murphy, P. J. M., Gaillard, S., Zhao, X., Wu, J.-T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., & Yao, T.-P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.021 · Cited by 1,153
Structure and mechanism of the Hsp90 molecular chaperone machinery
Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103
The 90-kDa Molecular Chaperone Family
Csermely, P., Schnaider, T., So″ti, C., Prohászka, Z., & Nardai, G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00013-8 · Cited by 1,028
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004
Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex
Ali, M. M. U., Roe, S. M., Vaughan, C. K., Meyer, P., Panaretou, B., Piper, P. W., Prodromou, C., & Pearl, L. H. (2006) · Nature · doi:10.1038/nature04716 · Cited by 962
Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis
Dai, C., Whitesell, L., Rogers, A. B., & Lindquist, S. (2007) · Cell · doi:10.1016/j.cell.2007.07.020 · Cited by 826
Zhao, R., Davey, M., Hsu, Y.-C., Kaplanek, P., Tong, A., Parsons, A. B., Krogan, N., Cagney, G., Mai, D., Greenblatt, J., et al. (2005) · Cell · doi:10.1016/j.cell.2004.12.024 · Cited by 819
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F. P., Li, M., Yagyu, R., & Nakamura, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1151 · Cited by 731
Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050172 · Cited by 596
Pal, S., Vishwanath, S. N., Erdjument-Bromage, H., Tempst, P., & Sif, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9630-9645.2004 · Cited by 592
Eustace, B. K., Sakurai, T., Stewart, J. K., Yimlamai, D., Unger, C., Zehetmeier, C., Lain, B., Torella, C., Henning, S. W., Beste, G., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1131 · Cited by 590
Self-citationWandinger, S. K., Richter, K., & Buchner, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800007200 · Cited by 546
Activation of the ATPase Activity of Hsp90 by the Stress-Regulated Cochaperone Aha1
Panaretou, B., Siligardi, G., Meyer, P., Maloney, A., Sullivan, J. K., Singh, S., Millson, S. H., Clarke, P. A., Naaby-Hansen, S., Stein, R., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00785-2 · Cited by 542
Self-citationWORKMAN, P., BURROWS, F., NECKERS, L., & ROSEN, N. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.012 · Cited by 521
Self-citationBanerji, U., O'Donnell, A., Scurr, M., Pacey, S., Stapleton, S., Asad, Y., Simmons, L., Maloney, A., Raynaud, F., Campbell, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.612 · Cited by 488
Eccles, S. A., Massey, A., Raynaud, F. I., Sharp, S. Y., Box, G., Valenti, M., Patterson, L., de Haven Brandon, A., Gowan, S., Boxall, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5256 · Cited by 479
Diverse Cellular Functions of the Hsp90 Molecular Chaperone Uncovered Using Systems Approaches
McClellan, A. J., Xia, Y., Deutschbauer, A. M., Davis, R. W., Gerstein, M., & Frydman, J. (2007) · Cell · doi:10.1016/j.cell.2007.07.036 · Cited by 474
Mimnaugh, E. G., Chavany, C., & Neckers, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22796 · Cited by 466
Self-citationHeat Shock Protein 70 (Hsp70) as an Emerging Drug Target
Evans, C. G., Chang, L., & Gestwicki, J. E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100054f · Cited by 436
An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function
Scroggins, B. T., Robzyk, K., Wang, D., Marcu, M. G., Tsutsumi, S., Beebe, K., Cotter, R. J., Felts, S., Toft, D., Karnitz, L., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.008 · Cited by 413
Self-citationDisassembly of Transcriptional Regulatory Complexes by Molecular Chaperones
Freeman, B. C., & Yamamoto, K. R. (2002) · Science · doi:10.1126/science.1073051 · Cited by 400
The hsp90-related Protein TRAP1 Is a Mitochondrial Protein with Distinct Functional Properties
Felts, S. J., Owen, B. A. L., Nguyen, P., Trepel, J., Donner, D. B., & Toft, D. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3305 · Cited by 370
Self-citationA novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
Zhang, T., Hamza, A., Cao, X., Wang, B., Yu, S., Zhan, C.-G., & Sun, D. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0484 · Cited by 363
Modulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228
Yu, X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.504 · Cited by 360
Protein Kinase CK2 in Health and Disease: CK2: A key player in cancer biology
Trembley, J. H., Wang, G., Unger, G., Slaton, J., & Ahmed, K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-9154-y · Cited by 354
Kelland, L. R., Sharp, S. Y., Rogers, P. M., Myers, T. G., & Workman, P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1940 · Cited by 350
Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90
Hessling, M., Richter, K., & Buchner, J. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1565 · Cited by 349
Martínez-Ruiz, A., Villanueva, L., de Orduña, C. G., López-Ferrer, D., Higueras, M. Á., Tarín, C., Rodríguez-Crespo, I., Vázquez, J., & Lamas, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407294102 · Cited by 330
Antimyeloma activity of heat shock protein-90 inhibition
Mitsiades, C. S. (2005) · Blood · doi:10.1182/blood-2005-03-1158 · Cited by 319
Caldas-Lopes, E., Cerchietti, L., Ahn, J. H., Clement, C. C., Robles, A. I., Rodina, A., Moulick, K., Taldone, T., Gozman, A., Guo, Y., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903392106 · Cited by 315
Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Donnelly, A., & Blagg, B. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242895 · Cited by 313
Update on Hsp90 Inhibitors in Clinical Trial
Kim, Y., Alarcon, S., Lee, S., Lee, M.-J., Giaccone, G., Neckers, L., & Trepel, J. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789895728 · Cited by 311
Self-citationGrbovic, O. M., Basso, A. D., Sawai, A., Ye, Q., Friedlander, P., Solit, D., & Rosen, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609973103 · Cited by 308
Dual Targeting of HSC70 and HSP72 Inhibits HSP90 Function and Induces Tumor-Specific Apoptosis
Powers, M. V., Clarke, P. A., & Workman, P. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.002 · Cited by 307
Structure of an Hsp90-Cdc37-Cdk4 Complex
Vaughan, C. K., Gohlke, U., Sobott, F., Good, V. M., Ali, M. M. U., Prodromou, C., Robinson, C. V., Saibil, H. R., & Pearl, L. H. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.07.016 · Cited by 293
Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery
Meyer, P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600141 · Cited by 291
Mice lacking HSP90β fail to develop a placental labyrinth
Voss, A. K., Thomas, T., & Gruss, P. (2000) · Development · doi:10.1242/dev.127.1.1 · Cited by 282
Structures of GRP94-Nucleotide Complexes Reveal Mechanistic Differences between the hsp90 Chaperones
Dollins, D. E., Warren, J. J., Immormino, R. M., & Gewirth, D. T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.024 · Cited by 281
Extracellular heat shock protein‐90α: linking hypoxia to skin cell motility and wound healing
Li, W., Li, Y., Guan, S., Fan, J., Cheng, C., Bright, A. M., Chinn, C., Chen, M., & Woodley, D. T. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601579 · Cited by 280
Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons
Specchia, V., Piacentini, L., Tritto, P., Fanti, L., D’Alessandro, R., Palumbo, G., Pimpinelli, S., & Bozzetti, M. P. (2010) · Nature · doi:10.1038/nature08739 · Cited by 265
Structure and Functional Relationships of Hsp90
Prodromou, C., & Pearl, L. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481877 · Cited by 261
Zoubeidi, A., Zardan, A., Beraldi, E., Fazli, L., Sowery, R., Rennie, P., Nelson, C., & Gleave, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2057 · Cited by 256
The large conformational changes of Hsp90 are only weakly coupled to ATP hydrolysis
Mickler, M., Hessling, M., Ratzke, C., Buchner, J., & Hugel, T. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1557 · Cited by 254
da Rocha Dias, S., Friedlos, F., Light, Y., Springer, C., Workman, P., & Marais, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2632 · Cited by 246
Chaperoning of Glucocorticoid Receptors
Pratt, W. B., Morishima, Y., Murphy, M., & Harrell, M. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-29717-0_5 · Cited by 245
Asymmetric Activation of the Hsp90 Dimer by Its Cochaperone Aha1
Retzlaff, M., Hagn, F., Mitschke, L., Hessling, M., Gugel, F., Kessler, H., Richter, K., & Buchner, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.006 · Cited by 244
Grem, J. L., Morrison, G., Guo, X.-D., Agnew, E., Takimoto, C. H., Thomas, R., Szabo, E., Grochow, L., Grollman, F., Hamilton, J. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.085 · Cited by 242
Self-citationKang, B. H., Plescia, J., Song, H. Y., Meli, M., Colombo, G., Beebe, K., Scroggins, B., Neckers, L., & Altieri, D. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37613 · Cited by 240
Self-citationCi, W., Polo, J. M., Cerchietti, L., Shaknovich, R., Wang, L., Yang, S. N., Ye, K., Farinha, P., Horsman, D. E., Gascoyne, R. D., et al. (2009) · Blood · doi:10.1182/blood-2008-12-193037 · Cited by 239
The Hsp90 chaperone controls the biogenesis of L7Ae RNPs through conserved machinery
Boulon, S., Marmier-Gourrier, N., Pradet-Balade, B., Wurth, L., Verheggen, C., Jády, B. E., Rothé, B., Pescia, C., Robert, M.-C., Kiss, T., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708110 · Cited by 238
Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility
Echeverria, P. C., & Picard, D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.11.012 · Cited by 227
Southworth, D. R., & Agard, D. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.024 · Cited by 224
Role of Acetylation and Extracellular Location of Heat Shock Protein 90α in Tumor Cell Invasion
Yang, Y., Rao, R., Shen, J., Tang, Y., Fiskus, W., Nechtman, J., Atadja, P., & Bhalla, K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0644 · Cited by 221
Cheng, C.-F., Fan, J., Fedesco, M., Guan, S., Li, Y., Bandyopadhyay, B., Bright, A. M., Yerushalmi, D., Liang, M., Chen, M., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01287-07 · Cited by 220
Cdk1-Dependent Regulation of the Mitotic Inhibitor Wee1
Harvey, S. L., Charlet, A., Haas, W., Gygi, S. P., & Kellogg, D. R. (2005) · Cell · doi:10.1016/j.cell.2005.05.029 · Cited by 208
Vaughan, C. K., Mollapour, M., Smith, J. R., Truman, A., Hu, B., Good, V. M., Panaretou, B., Neckers, L., Clarke, P. A., Workman, P., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.021 · Cited by 200
Self-citationAbu-Farha, M., Lambert, J.-P., Al-Madhoun, A. S., Elisma, F., Skerjanc, I. S., & Figeys, D. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700271-mcp200 · Cited by 198
Functional involvement of Tudor and dPRMT5 in the piRNA processing pathway in Drosophila germlines
Nishida, K. M., Okada, T. N., Kawamura, T., Mituyama, T., Kawamura, Y., Inagaki, S., Huang, H., Chen, D., Kodama, T., Siomi, H., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.365 · Cited by 197
Swe1Wee1-Dependent Tyrosine Phosphorylation of Hsp90 Regulates Distinct Facets of Chaperone Function
Mollapour, M., Tsutsumi, S., Donnelly, A. C., Beebe, K., Tokita, M. J., Lee, M.-J., Lee, S., Morra, G., Bourboulia, D., Scroggins, B. T., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.005 · Cited by 196
Self-citationLees-Miller, S. P., & Anderson, C. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81631-9 · Cited by 193
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
Solit, D. B., Osman, I., Polsky, D., Panageas, K. S., Daud, A., Goydos, J. S., Teitcher, J., Wolchok, J. D., Germino, F. J., Krown, S. E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1002 · Cited by 190
Hua, G., Zhang, Q., & Fan, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703196200 · Cited by 187
Heath, E. I., Hillman, D. W., Vaishampayan, U., Sheng, S., Sarkar, F., Harper, F., Gaskins, M., Pitot, H. C., Tan, W., Ivy, S. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0221 · Cited by 186
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
Cerchietti, L. C., Yang, S. N., Shaknovich, R., Hatzi, K., Polo, J. M., Chadburn, A., Dowdy, S. F., & Melnick, A. (2009) · Blood · doi:10.1182/blood-2008-07-168773 · Cited by 183
Targeting HSP70: The second potentially druggable heat shock protein and molecular chaperone?
Powers, M. V., Jones, K., Barillari, C., Westwood, I., Montfort, R. L. M. V., & Workman, P. (2010) · Cell Cycle · doi:10.4161/cc.9.8.11204 · Cited by 179
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion
Tsutsumi, S., Scroggins, B., Koga, F., Lee, M.-J., Trepel, J., Felts, S., Carreras, C., & Neckers, L. (2008) · Oncogene · doi:10.1038/sj.onc.1210897 · Cited by 178
Self-citationSreeramulu, S., Gande, S. L., Göbel, M., & Schwalbe, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900929 · Cited by 178
Guo, W., Reigan, P., Siegel, D., Zirrolli, J., Gustafson, D., & Ross, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2029 · Cited by 176
Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET.
Smith-Jones, P. M., Solit, D. B., Afroze, F., Rosen, N. X., & Larson, S. M. (2006) · PubMed · Cited by 173
Komatsu, S., Imoto, I., Tsuda, H., Kozaki, K.-I., Muramatsu, T., Shimada, Y., Aiko, S., Yoshizumi, Y., Ichikawa, D., Otsuji, E., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp116 · Cited by 173
Koulov, A. V., LaPointe, P., Lu, B., Razvi, A., Coppinger, J., Dong, M.-Q., Matteson, J., Laister, R., Arrowsmith, C., Yates, J. R., et al. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-12-1017 · Cited by 172
Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90
Vilenchik, M., Solit, D., Basso, A., Huezo, H., Lucas, B., He, H., Rosen, N., Spampinato, C., Modrich, P., & Chiosis, G. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.008 · Cited by 171
Hsp90 is regulated by a switch point in the C‐terminal domain
Retzlaff, M., Stahl, M., Eberl, H. C., Lagleder, S., Beck, J., Kessler, H., & Buchner, J. (2009) · EMBO reports · doi:10.1038/embor.2009.153 · Cited by 171
Sidera, K., Gaitanou, M., Stellas, D., Matsas, R., & Patsavoudi, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701803200 · Cited by 167
Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases
Becker, B., Multhoff, G., Farkas, B., Wild, P. ‐., Landthaler, M., Stolz, W., & Vogt, T. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00114.x · Cited by 167
The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts
Pratt, W. B., Morishima, Y., & Osawa, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800023200 · Cited by 162
Min, J.-N., Huang, L., Zimonjic, D. B., Moskophidis, D., & Mivechi, N. F. (2007) · Oncogene · doi:10.1038/sj.onc.1210317 · Cited by 162
Cerchietti, L. C., Lopes, E. C., Yang, S. N., Hatzi, K., Bunting, K. L., Tsikitas, L. A., Mallik, A., Robles, A. I., Walling, J., Varticovski, L., et al. (2009) · Nature Medicine · doi:10.1038/nm.2059 · Cited by 161
The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90
Wandinger, S. K., Suhre, M. H., Wegele, H., & Büchner, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600930 · Cited by 160
McCollum, A. K., TenEyck, C. J., Sauer, B. M., Toft, D. O., & Erlichman, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1629 · Cited by 157
Lancet, J. E., Gojo, I., Burton, M., Quinn, M. F., Tighe, S., Kersey, K., Zhong, Z., Albitar, M. X., Bhalla, K. N., Hannah, A. L., et al. (2010) · Leukemia · doi:10.1038/leu.2009.292 · Cited by 156
Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
Shimamura, T., Li, D., Ji, H., Haringsma, H. J., Liniker, E., Borgman, C. L., Lowell, A. M., Minami, Y., McNamara, K. L., Perera, S. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5428 · Cited by 156
Eiseman, J. L., Lan, J. Q., Lagattuta, T. F., Hamburger, D. R., Joseph, E., Covey, J. M., & Egorin, M. J. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0865-3 · Cited by 152
Peng, C., Brain, J. M., Hu, Y., Goodrich, A., Kong, L., Grayzel, D., Pak, R. H., Read, M. A., & Li, S. (2007) · Blood · doi:10.1182/blood-2006-10-054098 · Cited by 150
Morra, G., Verkhivker, G. M., & Colombo, G. (2009) · PLoS Comput. Biol. · doi:10.1371/journal.pcbi.1000323 · Cited by 149
Echeverría, P. C., Mazaira, G., Erlejman, A., Gomez-Sanchez, C., Pilipuk, G. P., & Galigniana, M. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00649-09 · Cited by 144
Minireview: Nuclear Receptors and Breast Cancer
Conzen, S. D. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0421 · Cited by 144
Hsp90: a chaperone for protein folding and gene regulation
Zhao, R., & Houry, W. A. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-158 · Cited by 144
Duval, M., Bœuf, F. L., Huot, J., & Gratton, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0467 · Cited by 143
Holland, J. P., Caldas-Lopes, E., Divilov, V., Longo, V. A., Taldone, T., Zatorska, D., Chiosis, G., & Lewis, J. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008859 · Cited by 142
Maloney, A., Clarke, P. A., Naaby‐Hansen, S., Stein, R. C., Koopman, J.-O., Akpan, A., Yang, A., Zvelebil, M., Cramer, R., Stimson, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2968 · Cited by 140
Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma
Old, W. M., Shabb, J. B., Houel, S., Wang, H., Couts, K. L., Yen, C.-Y., Litman, E. S., Croy, C. H., Meyer-Arendt, K., Miranda, J. G., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.007 · Cited by 137
Signalling molecules essential for neuronal survival and differentiation
Frebel, K., & Wiese, S. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341287 · Cited by 136
Holmes, J. L., Sharp, S. Y., Hobbs, S., & Workman, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3268 · Cited by 135
Leav, I., Plescia, J., Goel, H. L., Li, J., Jiang, Z., Cohen, R. J., Languino, L. R., & Altieri, D. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090521 · Cited by 133
Structural and functional coupling of Hsp90‐ and Sgt1‐centred multi‐protein complexes
Zhang, M., Botër, M., Li, K., Kadota, Y., Panaretou, B., Prodromou, C., Shirasu, K., & Pearl, L. H. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.190 · Cited by 131
Castro, J. E., Prada, C. E., Loria, O., Kamal, A., Chen, L., Burrows, F. J., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2005-03-1099 · Cited by 127
Structural Studies on the Co-chaperone Hop and Its Complexes with Hsp90
Onuoha, S. C., Coulstock, E. T., Grossmann, J. G., & Jackson, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.013 · Cited by 127
Chandarlapaty, S., Scaltriti, M., Angelini, P. D., Ye, Q., Guzmán, M., Hudis, C. A., Norton, L., Solit, D. B., Arribas, J., Baselga, J. M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.337 · Cited by 126
Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression
Tariq, M., Nussbaumer, U., Chen, Y., Beisel, C., & Paro, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809669106 · Cited by 125
Gaspar, N., Sharp, S. Y., Pacey, S., Jones, C., Walton, M. I., Vassal, G., Eccles, S. A., Pearson, A. D. J., & Workman, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3131 · Cited by 124
Kummar, S., Gutierrez, M. E., Gardner, E. R., Chen, X., Figg, W. D., Zajac‐Kaye, M., Chen, M., Steinberg, S. M., Muir, C. A., Yancey, M. A., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.026 · Cited by 122
Self-citationHSP90 regulates cell survival via inositol hexakisphosphate kinase-2
Chakraborty, A., Koldobskiy, M. A., Sixt, K. M., Juluri, K. R., Mustafa, A. K., Snowman, A. M., van Rossum, D. B., Patterson, R. L., & Snyder, S. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711168105 · Cited by 118
Ruiz, M. I. G., Floor, K., Roepman, P., Rodríguez, J. A., Meijer, G. A., Mooi, W. J., Jassem, E., Nikliński, J., Muley, T., van Zandwijk, N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001722 · Cited by 118
Self-citationDimerization of Hsp90 Is Required for in Vivo Function
Wayne, N., & Bolon, D. N. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703844200 · Cited by 117
FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML
Weisberg, E., Barrett, R., Liu, Q., Stone, R. M., Gray, N. S., & Griffin, J. D. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.04.001 · Cited by 116
The ATPase Cycle of the Endoplasmic Chaperone Grp94
Frey, S., Leskovar, A., Reinstein, J., & Büchner, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704647200 · Cited by 109
Gray, P. J., Stevenson, M. A., & Calderwood, S. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3162 · Cited by 107
Hsp90 phosphorylation, Wee1 and the cell cycle
Mollapour, M., Tsutsumi, S., & Neckers, L. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12054 · Cited by 104
Self-citationShiotsu, Y., Neckers, L. Μ., Wortman, I. A., An, W. G., Schulte, T. W., Soga, S., Murakata, C., Tamaoki, T., & Akinaga, S. (2000) · Blood · doi:10.1182/blood.v96.6.2284 · Cited by 102
Self-citationMimnaugh, E. G., Worland, P. J., Whitesell, L. J., & Neckers, L. Μ. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28654 · Cited by 102
Self-citationIndependent ATPase Activity of Hsp90 Subunits Creates a Flexible Assembly Platform
McLaughlin, S. H., Ventouras, L.-A., Lobbezoo, B., & Jackson, S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.055 · Cited by 102
The ATPase Cycle of the Mitochondrial Hsp90 Analog Trap1
Leskovar, A., Wegele, H., Werbeck, N. D., Büchner, J., & Reinstein, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709516200 · Cited by 100
Shelton, S. N., Shawgo, M. E., Matthews, S. B., Lu, Y., Donnelly, A. C., Szabla, K., Tanol, M., Vielhauer, G. A., Rajewski, R. A., Matts, R. L., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058545 · Cited by 99
Protein Kinase CK2 in Health and Disease: CK2: The kinase controlling the Hsp90 chaperone machinery
Miyata, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-9152-0 · Cited by 98
Mimnaugh, E. G., Xu, W., Vos, M. D., Yuan, X., & Neckers, L. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0019 · Cited by 98
Self-citationThe Hsp90 Molecular Chaperone Modulates Multiple Telomerase Activities
Toogun, O. A., DeZwaan, D. C., & Freeman, B. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01417-07 · Cited by 98
Krämer-Marek, G., Kiesewetter, D. O., & Capala, J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057695 · Cited by 97
Yano, A., Tsutsumi, S., Soga, S., Lee, M.-J., Trepel, J. B., Osada, H., & Neckers, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805354105 · Cited by 94
Self-citationChaperoning Checkpoint Kinase 1 (Chk1), an Hsp90 Client, with Purified Chaperones
Arlander, S. J. H., Felts, S. J., Wagner, J. M., Stensgard, B. A., Toft, D. O., & Karnitz, L. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508687200 · Cited by 93
Fionda, C., Soriani, A., Malgarini, G., Iannitto, M. L., Santoni, A., & Cippitelli, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901797 · Cited by 91
Kurokawa, M., Zhao, C., Reya, T., & Kornbluth, S. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00265-08 · Cited by 89
Ramanathan, R. K., Egorin, M. J., Erlichman, C., Remick, S. C., Ramalingam, S. S., Naret, C., Holleran, J. L., TenEyck, C. J., Ivy, S. P., & Belani, C. P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0415 · Cited by 89
Extracellular HSP90: Conquering the cell surface
Sidera, K., & Patsavoudi, E. (2008) · Cell Cycle · doi:10.4161/cc.7.11.6054 · Cited by 88
p23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity
Forafonov, F., Toogun, O. A., Grad, I., Suslova, E., Freeman, B. C., & Picard, D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02246-07 · Cited by 84 · cited 1×
“Some co-chaperones, including activator of HSP90 ATPase 1 ( AHA1 ), prostaglandin E synthase 3 (PTGES3; also known as p23), STIP1 (also known as p60HOP), and cell division cycle 37 homologue ( CDC37 ), modulate the rate of the HSP90 cycle by affecting the conformational dynamics of the chaperon”
BackgroundTsutsumi, S., Mollapour, M., Graf, C., Lee, C., Scroggins, B. T., Xu, W., Haslerova, L., Heßling, M., Konstantinova, A. A., Trepel, J. B., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1682 · Cited by 83
Self-citationModulation of Hsf1 activity by novobiocin and geldanamycin
Condé, R., Belak, Z. R., Nair, M., O’Carroll, R. F., & Ovsenek, N. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-049 · Cited by 81
Heat Shock Protein 90 Inhibition in Lung Cancer
Shimamura, T., & Shapiro, G. I. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318174ea3a · Cited by 79
Tanespimycin: the opportunities and challenges of targeting heat shock protein 90
Erlichman, C. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902953699 · Cited by 79
HSP90: The Rosetta stone for cellular protein dynamics?
DeZwaan, D. C., & Freeman, B. C. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5723 · Cited by 73
Immormino, R. M., Metzger, L. E., Reardon, P. N., Dollins, D. E., Blagg, B. S. J., & Gewirth, D. T. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.071 · Cited by 72
Targeting CDC37: An alternative, kinase-directed strategy for disruption of oncogenic chaperoning
Smith, J. R., & Workman, P. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7531 · Cited by 67
Radanyi, C., Bras, G. L., Marsaud, V., Peyrat, J., Messaoudi, S., CATELLI, M. G., Brion, J., Alami, M., & Renoir, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.001 · Cited by 64
New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check
O’Hare, T., Eide, C. A., & Deininger, M. W. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.6.865 · Cited by 63
Expression of Hsp90 chaperome proteins in human tumor tissue
McDowell, C. L., Sutton, R. B., & Obermann, W. M. J. (2009) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2009.06.012 · Cited by 61
Sekimoto, T., Oda, T., Pozo, F. M., Murakumo, Y., Masutani, C., Hanaoka, F., & Yamashita, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2009.12.015 · Cited by 61
Tse, A. N., Klimstra, D. S., Gönen, M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1006 · Cited by 59
Structural Basis of the Radicicol Resistance Displayed by a Fungal Hsp90
Prodromou, C., Nuttall, J. M., Millson, S. H., Roe, S. M., Sim, T., Tan, D., Workman, P., Pearl, L. H., & Piper, P. W. (2009) · ACS Chemical Biology · doi:10.1021/cb9000316 · Cited by 56
Post-translational modification of heat-shock protein 90: impact on chaperone function
Scroggins, B. T., & Neckers, L. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.10.1403 · Cited by 52
Self-citationAnnamalai, B., Liu, X., Gopal, U., & Isaacs, J. S. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0582 · Cited by 51
Matthews, S. B., Vielhauer, G. A., Manthe, C. A., et al. (2009) · The Prostate · doi:10.1002/pros.21035 · Cited by 47
Novel Hsp90 partners discovered using complementary proteomic approaches
Tsaytler, P. A., Krijgsveld, J., Goerdayal, S. S., Rüdiger, S., & Egmond, M. R. (2009) · Cell Stress and Chaperones · doi:10.1007/s12192-009-0115-z · Cited by 46
Xu, W., Soga, S., Beebe, K. L., Lee, M.-J., Kim, Y. S., Trepel, J. B., & Neckers, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603950 · Cited by 44
Self-citationPeng, C., Li, D., & Li, S. (2007) · Cell Cycle · doi:10.4161/cc.6.18.4722 · Cited by 44
Tse, A. N., Sheikh, T. N., Ho, A. L., Chou, T., & Schwartz, G. K. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050807 · Cited by 43
Compton, S. A., Elmore, L. W., Haydu, K., Jackson‐Cook, C. K., & Holt, S. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1452-1462.2006 · Cited by 41
Kawabe, M., Mandić, M., Taylor, J. L., Vasquez, C. A., Wesa, A. K., Neckers, L. Μ., & Storkus, W. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4511 · Cited by 39
Self-citationHubbard, J. M., Erlichman, C., Toft, D. O., Qin, R., Stensgard, B. A., Felten, S. J., Eyck, C. T., Batzel, G. N., Ivy, S. P., & Haluska, P. (2010) · Investigational New Drugs · doi:10.1007/s10637-009-9381-y · Cited by 38
The Role of IRF1 and IRF2 Transcription Factors in Leukaemogenesis
Choo, A., Palladinetti, P., Passioura, T., Shen, S., Lock, R. B., Symonds, G. P., & Dolnikov, A. (2006) · Current Gene Therapy · doi:10.2174/156652306778520683 · Cited by 29
Miyata, Y., & Nishida, E. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9818-1 · Cited by 26
Wesa, A. K., Herrem, C. J., Mandić, M., Taylor, J. L., Vasquez, C. A., Kawabe, M., Tatsumi, T., Leibowitz, M. S., Finke, J. H., Bukowski, R. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7721 · Cited by 26
Narayan, V., Eckert, M. J., Żylicz, M., Żylicz, M., & Ball, K. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019505 · Cited by 25
Molecular Pathology of Mixed-Lineage Leukemia
Bach, C., & Slany, R. K. (2009) · Future Oncology · doi:10.2217/fon.09.96 · Cited by 14
Richardson, P. G. G., Chanan-Khan, A. A., Lonial, S., et al. (2009) · Blood · doi:10.1182/blood.v114.22.2890.2890 · Cited by 13
Research works printed but not linked: 15
- Chiosis, G. & Tao, H. Purine-scaffold Hsp90 inhibitors. IDrugs 9, 778–782 (2006).
- Au, Q., Zhang, Y., Barber, J. R., Ng, S. C. & Zhang, B. Identification of inhibitors of HSF1 functional activity by high-content target-based screening. J. Biomol. Screen. 14, 1165–1175 (2009). · doi:10.1177/1087057109347472
- Modi, S. et al. Phase II trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC). J. Clin. Oncol. Abstr. 26, 1027 (2008). · doi:10.1200/jco.2008.26.15_suppl.1027
- Hwang, M., Moretti, L. & Lu, B. HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy. Curr. Med. Chem. 16, 3081–3092 (2009). · doi:10.2174/092986709788802999
- Reikvam, H., Ersvaer, E. & Bruserud, O. Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia. Curr. Cancer Drug Targets 9, 761–776 (2009). · doi:10.2174/156800909789271486
- Elfiky, A. et al. BIIB021, an oral, synthetic non-ansamycin Hsp90 inhibitor: phase I experience. J. Clin. Oncol. Abstr. 26, 2503 (2008). · doi:10.1200/jco.2008.26.15_suppl.2503
- Sequist, L. V. et al. A phase II trial of IPI-504 (retaspimycin hydrochloride), a novel Hsp90 inhibitor, in patients with relapsed and/or refractory stage IIIb or stage IV non-small cell lung cancer (NSCLC) stratified by EGFR mutation status. J. Clin. Oncol. Abstr. 27, 8073 (2009). · doi:10.1200/jco.2009.27.15_suppl.8073
- Dakappagari, N. et al. An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors. Biomarkers 15, 31–38 (2009). · doi:10.3109/13547500903261347
- Demetri, G. D. et al. Inhibition of the heat shock protein 90 (Hsp90) chaperone with the novel agent IPI-504 to overcome resistance to tyrosine kinase inhibitors (TKIs) in metastatic GIST: updated results of a phase I trial. J. Clin. Oncol. Abstr. 25, 10024 (2007). · doi:10.1200/jco.2007.25.18_suppl.10024
- Oude Munnink, T. H. et al. 89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft. Eur. J. Cancer 46, 678–684 (2009). · doi:10.1016/j.ejca.2009.12.009
- Le, H. C. et al. Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r. Magn. Reson. Med. 62, 1112–1119 (2009). · doi:10.1002/mrm.22137
- Chung, Y. L. et al. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino, 17-demethoxygeldanamycin (17AAG) in human colon cancer models. J. Natl Cancer Inst. 95, 1624–1633 (2003). · doi:10.1093/jnci/djg084
- Liu, D. et al. Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin. Br. J. Cancer 87, 783–789 (2002). · doi:10.1038/sj.bjc.6600558
- Hadchity, E. et al. Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma. Mol. Ther. 17, 1387–1394 (2009). · doi:10.1038/mt.2009.90
- Stuehler, C. et al. Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease. Blood 114, 2829–2836 (2009). · doi:10.1182/blood-2009-06-224600
Cited by
Schopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540
Induced protein degradation: an emerging drug discovery paradigm
Lai, A. C., & Crews, C. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.211 · Cited by 1,486
Fever and the thermal regulation of immunity: the immune system feels the heat
Evans, S. S., Repasky, E. A., & Fisher, D. T. (2015) · Nature Reviews Immunology · doi:10.1038/nri3843 · Cited by 1,257
Chaperone machines for protein folding, unfolding and disaggregation
Saibil, H. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3658 · Cited by 1,169
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
Doane, T. L., & Burda, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15260f · Cited by 1,098
Metadata
- Authors
- Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L.
- Venue
- Nature Reviews Cancer
- Published
- 2010-08
- Volume
- 10
- Issue
- 8
- Pages
- 537-549
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2060902443
- Cited by
- 1,514
- References
- 160
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.